SLC38A2 and pancreatic neoplasm: In view of the fact that SLC38A2 and SLC1A4 compete for alanine in pancreatic cancer, we speculated whether SLC38A2, which is highly expressed in DCs, also has a similar phenomenon in the immune microenvironment to meet its function.